EZH2 and myeloproliferative disorder: Additional mutations were found in 5/9 (56%), including ASXL1 (n = 2; one PV, one ET) and single occurrences of EZH2, DNMT3A, TET2, BCOR, and NF1 mutations (across PV, ET, MPN-U).